The Role of Fibrin-Related Markers in Disseminated Intravascular Coagulation Due to Sepsis
DOI:
https://doi.org/10.24293/ijcpml.v28i3.1996Keywords:
Sepsis, DIC, FRMsAbstract
Sepsis leads to local and systemic activation of different response systems, including coagulation and fibrinolysis. An overwhelming inflammatory response may lead to organ failure, and the coagulation and fibrinolysis involvement may lead to Disseminated Intravascular Coagulation (DIC). Special regard is given to the diagnosis of DIC by the use of scoring systems, which are, APACHE II, SAPS II, International Society of Thrombosis and Hemostasis (ISTH), and Japanese Ministry of Health and Welfare (JMHW). A large variety of fibrin compounds can be detected in plasma from septic patients with intravascular coagulation activation. Coagulation activation is indicated by elevated plasma levels of D-dimer, prothrombin fragments, and Thrombin-Antithrombin (TAT) complexes. Fibrin-Related Markers (FRMs) identified in sepsis are D-dimer, fibrinogen, Soluble Fibrin Monomer (SFM), and Fibrin Degradation Products (FDP). Hemostatic molecular markers, such as TAT, Plasmin-Plasmin Inhibitor Complex (PPIC), D-dimer, and SFM are better for the diagnosis of pre-DIC. No single biomarker of sepsis may be ideal, but many are helpful in terms of at least identifying critically ill patients who need more careful monitoring. As each biomarker has limited sensitivity and specificity, it may be interesting to combine several biomarkers. The purpose of this literature review was to increase knowledge about laboratory tests of FRMs and provide current knowledge and insight into these biomarkers related to DIC-sepsis. The method used in this literature review was a traditional review. Search, identify, and select relevant literature on PubMed–CBI and Google Scholar based on keywords, 30 journals were obtained from the two search engines.Downloads
References
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA, 2016; 315(8): 801–810.
Gul̈ F, Arslantaş MK, Cinel I,̇ Kumar A. Changing definitions of sepsis. Turk J Anaesthesiol Reanim, 2017; 45: 129-38.
Gyawali B, Ramakrishna K, Dhamoon AS. Sepsis: The evolution in definition, pathophysiology, and
management. SAGE Open Med, 2019; 7: 2050312119835043.
Levi M, van der Poll T. Review article: Coagulation and sepsis. Thrombosis Research, 2017; 149: 38–44.
Gris JC, Cochery-Nouvellon E, Bouvier S, Jaber S, Albanese J, et al. Clinical value of automated fibrin
generation markers in patients with septic shock: A SepsiCoag ancillary study. British Society for
Haematology and John Wiley & Sons Ltd, 2018; 108(4): 636-647.
Iba T, Levy JH. Sepsis-induced coagulopathy and disseminated intravascular coagulation. The American Society of Anesthesiologists, Inc. All Rights Reserved. Anesthesiology 2020; 132:1238–45.
Papageorgiou C, Jourdi G, Adjambri E, Walborn A, Patel P, Fareed J. Disseminated intravascular coagulation: An update on pathogenesis, diagnosis, and therapeutic strategies Clinical and Applied Thrombosis/Hemostasis, 2018; 24(9S): 8S-28.
Rhee C, Gohil S, Klompas M. Regulatory mandates for sepsis care-reasons for caution. N Engl J Med, 2014; 370(18): 1673–1676. [PubMed: 24738642]
Saito S, Uchino S, Hayakawa M, Yamakawa K, Kudo D, et al. Japan Septic Disseminated Intravascular
Coagulation (JSEPTIC DIC) study group; Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems. Journal of Critical Care, 2018; 50: 23-30.
Ogura H, Gando S, Saitoh D, Takeyama N, Kushimoto S, et al. Japanese Association for Acute Medicine Sepsis Registry (JAAMSR) study group. Epidemiology of severe sepsis in Japanese intensive care units: A prospective multicenter study. J Infect Chemother, 2014; 20: 157-62.
Zaragoza JJ, Espinoza-Villafuerte MV. Minireviews: Current approach to disseminated intravascular coagulation related to sepsis-organ failure type. World J Hematol, 2017; 6(1): 11-16.
Toh CH, Alhamdi Y, Abrams ST. Current pathological and laboratory considerations in the diagnosis of disseminated intravascular coagulation. Ann Lab Med, 2016; 36: 505-512.
Larsen JB, Aggerbeck MA, Granfeldt, A, Schmidt, M, Hvas, AM, Adelborg K. Disseminated intravascular coagulation diagnosis: Positive predictive value of the ISTH score in a Danish population. Res Pract Thromb Haemost, 2021; 5(8): e12636.
Helms J, Severac F, Merdji H, Clere-Jehl R, François B, et al. Performances of disseminated intravascular coagulation scoring systems in septic shock patients. Ann Intensive Care, 2020; 10(1): 92.
Iba T, Levy JH, Yamakawa K, Thachil J, Warkentin TE, et al. Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation. JTH, 2019; 17(8): 1265–8.
Ding R, Wang Z, Lin Y, Liu B, Zhang Z, Ma X. Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0: A retrospective study. Blood Coagul Fibrinolysis (Wolters Kluwer Health, Inc), 2018; 29:551–558.
Patel P, Walborn A, Rondina M, Fareed J, Hoppensteadt D. Markers of inflammation and infection in sepsis and disseminated intravascular coagulation. Clinical and Applied Thrombosis/Hemostasis, 2019; 25: 1076029619843338.
Pierrakos C, Vincent J-L, Sepsis biomarkers: A review. Critical Care, 2010; 14: R15
Rodgers GM, Lehman CM. Chapter 5: Hemostasis screening assays, in: Bennett ST, Lehman CM, Rodgers GM, Laboratory hemostasis: A practical guide for pathologists. Second Ed., Switzerland, Springer International Publishing, 2015; 69-76.
McKenzie SB, Williams JL. Clinical laboratory hematology. Global Ed., Third Ed., London, Pearson
Education Limited, 2016; 681-684. 21. Rodelo JR, De la Rosa G, Valencia ML, Ospina S, Arango
CM, Gómez CI, García A, Nuñez E, Jaimes FA. D-dimer is a significant prognostic factor in patients with
suspected infection and sepsis. Am J Emerg Med. 2012; 30(9): 1991-9.
Faix JD. Biomarkers of sepsis. Critical Reviews in Clinical Laboratory Sciences, 2013; 50(1): 23-36.
CDRH, Guidance for industry and FDA reviewers/staff. In-vitro diagnostic fibrin monomer paracoagulation test. U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health. Hematology and Pathology Branch Division of Clinical Laboratory Devices (Office of Device Evaluation), 2018. Available from: https://www.fda.
gov/medical-devices/guidance-documents-medical -devices-and-radiation-emitting-products/in-vitro
-diagnostic-fibrin-monomer-paracoagulation-test -final-guidance-industry-and-food-and-drug (accessed January 1, 2018).
Masuda T, Shoko T, Deguchi Y. Clinical investigation of coagulation markers for early detection of
sepsis-induced disseminated intravascular coagulation: A single-center, prospective observational study. Clinical and Applied Thrombosis/Hemostasis, 2018; 24(7): 1082-1087.
Seiji M. Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC. J Intensive Care Med, 2015; 3: 8. Available from: https://jintensivecare.biomedcentral. com/articles/10.1186/s40560-015-0075-6 (accessed January 1, 2018).
Park K-J, Kwon E-H, Kim H-J, Kim S-H, Evaluation of the diagnostic performance of fibrin monomer in
disseminated intravascular coagulation. Korean J Lab Med 2011; 31: 143-147.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
